Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nihati Rexiati

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oxford Medical Case Reports|February 20, 2026
A IgG4-related prostatitis caseWeizhe Han, Fang Yu, Nihati Rexiati, et al.
Oxford Medical Case Reports|October 28, 2024
Cases of consecutive ductal adenocarcinoma of the prostate carrying HRR mutation: case series and literature reviewWeizhe Han, Nihati Rexiati, Yongzhi Wang, et al.
Cellular Signalling|June 16, 2026
BMP5 suppresses malignant progression of clear cell renal cell carcinoma by promoting DNA damage accumulation and sustained DNA damage response signalingNihati Rexiati, Xizhen Zhao, Yongzhi Wang, et al.
Frontiers in Oncology|February 10, 2025
A case of <i>de novo</i> neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature reviewWeizhe Han, Nihati Rexiati, Fang Yu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oxford Medical Case Reports|February 20, 2026
A IgG4-related prostatitis caseWeizhe Han, Fang Yu, Nihati Rexiati, et al.
Oxford Medical Case Reports|October 28, 2024
Cases of consecutive ductal adenocarcinoma of the prostate carrying HRR mutation: case series and literature reviewWeizhe Han, Nihati Rexiati, Yongzhi Wang, et al.
Cellular Signalling|June 16, 2026
BMP5 suppresses malignant progression of clear cell renal cell carcinoma by promoting DNA damage accumulation and sustained DNA damage response signalingNihati Rexiati, Xizhen Zhao, Yongzhi Wang, et al.
Frontiers in Oncology|February 10, 2025
A case of <i>de novo</i> neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature reviewWeizhe Han, Nihati Rexiati, Fang Yu, et al.
Pageof 1